IPS Stock Analysis: Ipsos | PA
Consulting Services | PA, France | Market Cap: 1.630m EUR | 12M Return: 14.8% | FR0000073298 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.39M
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ipsos SA is a Paris-headquartered research firm founded in 1975 that delivers survey-based research services to corporate and institutional clients across Europe, the Middle East, Africa, the Americas, and Asia-Pacific. Its work spans the full information production chain, covering data collection, processing, analysis, reporting, and activation, supported by online, mobile, and device-agnostic survey tools, qualitative research, and a self-service platform called Ipsos.Digital. The company also runs specialty practices in audience measurement, brand tracking, customer experience, healthcare, public affairs, automotive, innovation, and behavioral science and neuroscience, while increasingly embedding artificial intelligence, machine learning, and data science into its analytics offerings through its Ipsos Knowledge Centre.
The firm operates in the highly fragmented global market research and consulting services industry, competing with peers such as NielsenIQ, Kantar, GfK, and the in-house research departments of large advertising holding companies. Its revenue model is largely project-based, with clients in sectors like consumer goods, healthcare, media, and automotive paying for customized research deliverables and ongoing tracking programs rather than standardized products.
- AI tools compress traditional survey labor costs and margins
- EMEA corporate research budgets remain under pressure from macro slowdown
- Dollar weakness and selective M&A shape reported revenue trajectory
| Net Income: 174.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.35 > 1.0 |
| NWC/Revenue: 12.34% < 20% (prev 13.79%; Δ -1.45% < -1%) |
| CFO/TA 0.10 > 3% & CFO 298.4m > Net Income 174.3m |
| Net Debt (489.8m) to EBITDA (403.0m): 1.22 < 3 |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.0m) vs 12m ago -3.20% < -2% |
| Gross Margin: 22.39% > 18% (prev 68.76%; Δ -46.37% > 0.5%) |
| Asset Turnover: 86.94% > 50% (prev 66.01%; Δ 20.93% > 0%) |
| Interest Coverage Ratio: 9.89 > 6 (EBIT TTM 298.4m / Interest Expense TTM 30.2m) |
| A: 0.10 (Total Current Assets 1.03b - Total Current Liabilities 719.5m) / Total Assets 2.99b |
| B: 0.06 (Retained Earnings 186.6m / Total Assets 2.99b) |
| C: 0.10 (EBIT TTM 298.4m / Avg Total Assets 2.92b) |
| D: 1.05 (Book Value of Equity 1.53b / Total Liabilities 1.46b) |
| Altman-Z'' = 2.68 = A |
| DSRI: 0.89 (Receivables 686.3m/568.5m, Revenue 2.54b/1.88b) |
| GMI: 3.07 (GM 68.76% / 22.39%) |
| AQI: 0.98 (AQ_t 0.61 / AQ_t-1 0.62) |
| SGI: 1.35 (Revenue 2.54b / 1.88b) |
| TATA: -0.04 (NI 174.3m - CFO 298.4m) / TA 2.99b) |
| Beneish M = -1.00 (Cap -4..+1) = D |
As of August 30, 2026, the stock is trading at EUR 39.40 with a total of 72,374 shares traded. Over the past week, the price has changed by +1.08%, over one month by -5.97%, over three months by +9.65% and over the past year by +14.77%.
Current recommended Stop Loss: 36.50 (which is 7.4% or 2.8 ATR below the current price).
Ipsos has no consensus analysts rating.
P/E Trailing = 9.745
P/E Forward = 7.3692
P/S = 0.6416
P/B = 1.064
P/EG = 1.4433
Revenue TTM = 2.54b EUR
EBIT TTM = 298.4m EUR
EBITDA TTM = 403.0m EUR
Long Term Debt = 507.8m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 55.9m EUR (from shortTermDebt, last quarter)
Debt = 780.1m EUR (from shortLongTermDebtTotal, last quarter) + Leases 139.1m
Net Debt = 489.8m EUR (calculated: Debt 780.1m - CCE 290.3m)
Enterprise Value = 2.12b EUR (1.63b + Debt 780.1m - CCE 290.3m)
Interest Coverage Ratio = 9.89 (Ebit TTM 298.4m / Interest Expense TTM 30.2m)
EV/FCF = 9.89x (Enterprise Value 2.12b / FCF TTM 214.3m)
FCF Yield = 10.11% (FCF TTM 214.3m / Enterprise Value 2.12b)
FCF Margin = 8.44% (FCF TTM 214.3m / Revenue TTM 2.54b)
Net Margin = 6.86% (Net Income TTM 174.3m / Revenue TTM 2.54b)
Gross Margin = 22.39% ((Revenue TTM 2.54b - Cost of Revenue TTM 1.97b) / Revenue TTM)
Gross Margin QoQ = 18.84% (prev 25.42%)
Tobins Q-Ratio = 0.71 (Enterprise Value 2.12b / Total Assets 2.99b)
Interest Expense / Debt = 3.87% (Interest Expense 30.2m / Debt 780.1m)
Taxrate = 25.88% (61.5m / 237.8m)
NOPAT = 221.2m (EBIT 298.4m * (1 - 25.88%))
Current Ratio = 1.44 (Total Current Assets 1.03b / Total Current Liabilities 719.5m)
Debt / Equity = 0.51 (Debt 780.1m / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = 1.22 (Net Debt 489.8m / EBITDA 403.0m)
Debt / FCF = 2.29 (Net Debt 489.8m / FCF TTM 214.3m)
Total Stockholder Equity = 1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.97% (Net Income 174.3m / Total Assets 2.99b)
RoE = 11.42% (Net Income TTM 174.3m / Total Stockholder Equity 1.53b)
RoCE = 14.67% (EBIT 298.4m / Capital Employed (Equity 1.53b + L.T.Debt 507.8m))
RoIC = 10.04% (NOPAT 221.2m / Invested Capital 2.20b)
WACC = 5.28% (E(1.63b)/V(2.41b) * Re(6.44%) + D(780.1m)/V(2.41b) * Rd(3.87%) * (1-Tc(0.26)))
Discount Rate = 6.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.16 | Cagr: -2.67%
[DCF] Terminal Value 76.72% ; FCFF base≈206.1m ; Y1≈225.0m ; Y5≈281.5m
[DCF] Fair Price = 91.27 (EV 4.31b - Net Debt 489.8m = Equity 3.82b / Shares 41.8m; r=8.35% [WACC [floored]]; 5y FCF grow 10.52% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: -26.08 | Revenue CAGR: -3.56% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=5.22 | Chg30d=-1.38% | Revisions=+0% | GrowthEPS=-5.0% | GrowthRev=+1.7%
EPS next Year (2027-12-31): EPS=5.66 | Chg30d=-0.28% | Revisions=+17% | GrowthEPS=+8.3% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: +12% (up=3, down=2)